Kohei Shitara
MD
Department Chief, GI Oncology
👥Biography 个人简介
Kohei Shitara at the National Cancer Center Hospital East has led pivotal trials of antibody-drug conjugates and targeted therapies in gastric and esophageal cancers. He was the principal investigator of DESTINY-Gastric01, demonstrating trastuzumab deruxtecan efficacy in HER2-positive gastric/GEJ cancer after prior trastuzumab, leading to regulatory approval. His work defines the modern treatment landscape for HER2-altered upper GI cancers.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Kohei Shitara 的研究动态
Follow Kohei Shitara's research updates
留下邮箱，当我们发布与 Kohei Shitara（National Cancer Center Hospital East）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment